Oesophageal cancer | Guidance and guideline topic | NICE

3 new

and

0 updated

products since January 2017.

NICE Pathways - mapping our guidance

NICE Guidelines

Barrett's oesophagus: ablative therapy (CG106) August 2010
Suspected cancer: recognition and referral (NG12) June 2015

Interventional procedures guidance

Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus (IPG497) July 2014
Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia (IPG355) September 2010
Minimally invasive oesophagectomy (IPG407) September 2011
Palliative photodynamic therapy for advanced oesophageal cancer (IPG206) January 2007
Photodynamic therapy for early-stage oesophageal cancer (IPG200) December 2006

Technology appraisal guidance

Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy (TA378) January 2016

Quality standards

Suspected cancer (QS124) June 2016

In development

Nivolumab for previously treated gastric or gastro-oesophageal junction cancer [ID1118] (GID-TA10151) August 2018 Technology appraisal guidance
Oesophago-gastric cancer (GID-CGWAVE0801) January 2018 NICE guidelines
Pertuzumab for untreated metastatic HER2-positive gastric or gastro-oesophageal junction cancer [ID1096] (GID-TA10159) TBC Technology appraisal guidance